VGICX
Price
$71.77
Change
+$0.07 (+0.10%)
Updated
Aug 18 closing price
Net Assets
6.32B
VIVIX
Price
$70.32
Change
+$0.01 (+0.01%)
Updated
Aug 18 closing price
Net Assets
195.81B
Interact to see
Advertisement

VGICX vs VIVIX

Header iconVGICX vs VIVIX Comparison
Open Charts VGICX vs VIVIXBanner chart's image
JPMorgan US Value C
Price$71.77
Change+$0.07 (+0.10%)
VolumeN/A
Net Assets6.32B
Vanguard Value Index I
Price$70.32
Change+$0.01 (+0.01%)
VolumeN/A
Net Assets195.81B
VGICX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VGICX vs. VIVIX commentary
Aug 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VGICX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. VGICX (6.33B). VIVIX pays higher dividends than VGICX: VIVIX (2.19) vs VGICX (0.89). VGICX was incepted earlier than VIVIX: VGICX (28 years) vs VIVIX (27 years). VGICX (1.50) is less costly to investors than VIVIX (0.04). VGICX is a more actively managed with annual turnover of: 18.00 vs. VIVIX (9.00). VGICX has a lower initial minimum investment than VIVIX: VGICX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.59 vs. VGICX (6.42). VGICX (71.47) and VIVIX (70.23) have equivalent 5 years return.
VGICXVIVIXVGICX / VIVIX
Total Expense Ratio1.440.043,600%
Annual Report Gross Expense Ratio1.500.043,750%
Fund Existence28 years27 years-
Gain YTD6.1356.54894%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.33B196B3%
Annual Yield % from dividends0.892.1941%
Returns for 1 year6.427.5985%
Returns for 3 years26.9627.04100%
Returns for 5 years71.4770.23102%
Returns for 10 years95.94127.4575%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.05
+4.20%
PDS Biotechnology Corp
MASI153.930.06
+0.04%
Masimo Corp
TAVIU10.54N/A
N/A
Tavia Acquisition Corp
IMCR32.31-0.57
-1.73%
Immunocore Holdings plc
TNXP40.07-11.28
-21.97%
Tonix Pharmaceuticals Holding Corp